RxDoctor Payments Data

Charles Kays, MD

Plastic and Reconstructive Surgery · Wilmington, NCNPI 1689676611

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $51,000 of the $68,589 with a category attached, or 74.4%. Stryker accounts for 82.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $41,744 and has fallen 97.2% since, to $1,149 in 2025. Among plastic and reconstructive surgery clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$68,589in general payments, 2019–2025

Across 136 payments — averaging $504.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$56K
  • AbbVie$10K
  • TELA Bio, Inc.$2K
  • RTI Surgical, Inc$234
  • Integra Lifesciences Corporation$104
  • Mentor Worldwide LLC$20
  • plus $36 from 2 others

What the payments were for

  • Consulting fees$51,00074%
  • Speaking & faculty fees$8,37412%
  • Travel & lodging$5,0817%
  • Food & beverage$4,1256%
  • Education$80%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$68,589 in reported general payments places this provider in the 90th percentile of 55 plastic and reconstructive surgery providers in North Carolina.

See all plastic and reconstructive surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$35,953
Medicare patients
43
Services billed
120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin34$412
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$144
Clindamycin Hcl14$77
Oxycodone Hcl14$76
Cyclobenzaprine Hcl12$49
Promethazine Hcl21$49

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Wilmington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →